Geron Touts Pending Human Trial of ESCR—Again and Again and Again and Again

Geron has issued the latest in a long series of press releases claiming that it will soon be applying to the FDA for permission to conduct human trials of a medical trial created with ESCR. Why this is news beats me. As I have pointed out previously, it has been making the very same claim for years, to wit:

Some suggestion of a pending request was also strongly implied as far back as 2002.

This is not to say that this will be another false alarm. But it is to say that perhaps the media should be a little skeptical and report about the many false starts that Geron has previously made.

HT: David Prentice

Dear Reader,

Time is short, so I’ll be direct: FIRST THINGS needs you. And we need you by December 31 at 11:59 p.m., when the clock will strike zero. Give now at supportfirstthings.com.

First Things does not hesitate to call out what is bad. Today, there is much to call out. Yet our editors, authors, and readers like you share a greater purpose. And we are guided by a deeper, more enduring hope.

Your gift of $50, $100, or even $250 or more will bring this message of hope to many more people in the new year.

Make your gift now at supportfirstthings.com.

First Things needs you. I’m confident you’ll answer the call.

Make My Gift